<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648785/" ref="ordinalpos=4514&amp;ncbi_uid=1719252&amp;link_uid=PMC2648785" image-link="/pmc/articles/PMC2648785/figure/F6/" class="imagepopup">Figure 6.  From: Comparative analysis of the JAK/STAT <span class="highlight" style="background-color:">signaling</span> through erythropoietin receptor and thrombopoietin receptor using a systems approach. </a></div><br /><div class="p4l_captionBody"><b>The JAK/STAT pathway</b>. Each node indicates the component involving the transduction signaling or negative regulation of the pathway (R: receptor, JAK: JAK2, RJ: receptor-JAK2 complex, Ligand: Epo or Tpo, LRJ: ligand bound RJ, Pc: cytoplasmic phosphatase, Pn: nuclear phosphatase, SOCS: negative regulator). * and D denote a phosphorylation and a dimerization, respectively. According to the location in a cell, each molecule is tagged by c (cytoplasm) or n (nucleus). The system output was calculated by the level of nuclear phosphorylated STAT dimers (STAT*Dn).</div></div>